Agentix (AGTX) Non-Current Debt (2016 - 2019)
Agentix's (AGTX) quarterly Non-Current Debt came in at $85000.0 in Q3 2019, up 240.0% YoY from $25000.0 in Q3 2018, and down 22.73% on a QoQ basis from $110000.0 in Q2 2019.
Agentix (AGTX) Non-Current Debt (2016 - 2019) Analysis & Trends
Agentix (AGTX) has 4 years of Non-Current Debt data on file, last reported at $85000.0 in Q3 2019.
- Quarterly Non-Current Debt rose 240.0% year-over-year to $85000.0 in Q3 2019, while the trailing twelve-month figure through Aug 2019 was $85000.0 (up 240.0% YoY) and the FY2019 annual result came in at $85000.0, up 240.0% from the prior year.
- Non-Current Debt eased to $85000.0 in Q3 2019, from $110000.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $110000.0 in Q2 2019 to a low of $6933.0 in Q4 2016.
- A 4-year average of $54028.6 and a median of $49709.5 in 2017 frame the typical range for Non-Current Debt.
- The widest YoY moves for Non-Current Debt: up 940.79% in 2018, down 54.06% in 2018.
- Tracing AGTX's Non-Current Debt over 4 years: stood at $6933.0 in 2016, then jumped by 862.74% to $66747.0 in 2017, then slumped by 32.58% to $45000.0 in 2018, then soared by 88.89% to $85000.0 in 2019.
- The last three Non-Current Debt figures came in at $85000.0 (Q3 2019), $110000.0 (Q2 2019), and $100000.0 (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 8.96 Bn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2019 | 85,000.00 |
| May 31, 2019 | 110,000.00 |
| Feb 28, 2019 | 100,000.00 |
| Nov 30, 2018 | 45,000.00 |
| Aug 31, 2018 | 25,000.00 |
| May 31, 2018 | 25,000.00 |
| Feb 28, 2018 | 84,075.00 |
| Nov 30, 2017 | 66,747.00 |
| Aug 31, 2017 | 54,419.00 |
| May 31, 2017 | 38,091.00 |
| Feb 28, 2017 | 8,078.00 |
| Nov 30, 2016 | 6,933.00 |